FDA Import Refusal 1FX-9770955-3/10002/1 — BOEHRINGER INGELHEIM PROMECO S.A. De C.V.
The FDA refused shipment 1FX-9770955-3/10002/1 from BOEHRINGER INGELHEIM PROMECO S.A. De C.V. (Mexico) on Jul 16, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 16, 2026
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75